Objective: HIV preferentially affects white matter in the brain. Although combination antiretroviral therapy (cART) reduces HIV viral load within the brain, continued inflammation can persist. We investigated the effect of HIV and cART on white matter integrity.
Introduction
HIV enters the brain soon after seroconversion and can subsequently result in cognitive impairment [1] . The introduction of combination antiretroviral therapy (cART) has greatly reduced the severity of central nervous system (CNS) damage, but cognitive impairment continues to occur despite the introduction of these medications [2] . HIV-infected individuals receiving cART may continue to have persistent virus within the CNS resulting in neuroinflammation and white matter abnormalities [3] .
Diffusion tensor imaging (DTI) has become an increasingly popular method for studying in-vivo white matter structural integrity in neurodegenerative diseases [4] [5] [6] [7] . DTI measures the diffusion of water molecules in white matter, commonly represented within a voxel as an ellipsoid. Movement of water can be anisotropic with diffusion greater along the length of the fiber (longitudinal direction) than perpendicular to it (radial or transverse direction), as myelin fibers may restrict diffusion [8] . Diffusion along the major axis is assumed to reflect diffusivity parallel to the white matter tract and is termed axial diffusivity. The two minor axes can be averaged to determine radial diffusivity, which reflects diffusion perpendicular to the white matter [9] . Mean diffusivity reflects the average diffusion from all three directions. Finally, fractional anisotropy is a value between zero and one and provides a measure of the asymmetry of the general shape of the ellipsoid. A reduction in axial diffusivity could represent axonal compromise, whereas decreases in radial diffusivity may indicate myelin degradation [10] [11] [12] .
Diffusion tensor imaging has been used to study the effects of HIV on white matter integrity with variable results observed [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . In general, most studies have focused on two DTI metrics -fractional anisotropy and mean diffusivity. Within the corpus callosum and centrum semiovale (CSO) increases in mean diffusivity and decreases in fractional anisotropy have been seen in HIV-infected patients. These observed results may reflect the presence of edema which would tend to increase mean diffusivity. In addition, a disruption of the orderly structure of white matter fibers due to HIV would tend to decrease the fractional anisotropy [19] .
Only a few studies have assessed the impact of cART on white matter integrity in HIV-infected patients using DTI. Individuals have been typically classified according to serostatus, with HIV-infected patients receiving cART (HIVþ/cARTþ) and those naive to cART (HIVþ/ cARTÀ) merged into a single group. Pfefferbaum et al. [20] demonstrated that HIVþ/cARTÀ individuals (n ¼ 9) had significantly higher radial diffusivity values in the inferior cingulate bundle, occipital forceps, and superior longitudinal fasciculus compared to HIVuninfected controls (n ¼ 88) or HIVþ/cARTþ (n ¼ 33). However, Chen et al. [30] noted no significant differences in DTI parameters between HIVþ/cARTÀ (n ¼ 11) and HIVþ/cARTþ (n ¼ 18) patients within subcortical brain regions. More recently, a decrease in fractional anisotropy was seen in the temporal lobes of HIVþ/cARTþ (n ¼ 69) compared to HIVþ/cARTÀ (n ¼ 16) individuals [15] . In general, relatively few HIVþ/cARTÀ individuals have been examined in these post-cART era studies.
In this study, we analyzed white matter structural integrity within the genu, body, and splenium of the corpus callosum, as well as the CSO of 63 participants (21 HIV-uninfected controls, 21 HIVþ/cARTÀ, and 21 HIVþ/cARTþ). These regions were selected as they are relatively easy to delineate, provide more consistent sampling across individuals, and allow comparison to previous studies. Within a subgroup of HIVÀ/ cARTÀindividuals (n ¼ 10) we assessed the impact of therapy before and after commencing medications. We hypothesized that HIV-infected participants naive to cART may have significant differences in DTI parameters compared to either HIV-infected individuals receiving cARTor HIV-uninfected controls. Also, we hypothesized that cART may modulate HIV-associated white matter changes as seen in a longitudinal group that was followed both immediately prior to and approximately 6 months after starting therapy.
Methods

Participants
Sixty-three participants were selected from ongoing studies. Each participant provided written consent approved by the Institutional Review Board at Washington University in Saint Louis. Individuals with a history of confounding neurological disorders including epilepsy, stroke, head injury with loss of consciousness greater than 30 min, major psychiatric disorders, or active substance abuse were excluded from participation. Serological status of all HIV-infected participants was confirmed by documented positive HIV enzyme-linked immunoassay and Western blot or detection of plasma HIV RNA by PCR. All HIV-infected participants had laboratory evaluations (plasma CD4 cell count and HIV RNA viral load) performed at the time of neuroimaging. The cohort was further divided into three groups and consisted of HIV-uninfected controls (n ¼ 21), HIVþ/cARTþ patients (n ¼ 21), or HIVþ/cARTÀ patients (n ¼ 21). In addition, a subgroup of the HIVþ/cARTÀ patients (n ¼ 10) was longitudinally assessed immediately before and approximately 6 months after receiving a stable regimen.
Medications
The specific regimens that HIVþ/cARTþ patients received included: nucleoside reverse transcriptase inhibitors (NRTIs) þ non-nucleoside reverse transcriptase inhibitors (NNRTIs) (n ¼ 14), NRTIs þ protease inhibitors (n ¼ 11), or NRTIs only (n ¼ 1). For the longitudinal study, HIV-infected participants and their providers decided on the regimen. Within this longitudinal subgroup, HIV-infected participants received the following regimens: NRTIs þ NNRTIs (n ¼ 6) or NRTIs þ PIs (n ¼ 4). The ability of a particular antiretroviral medication to penetrate across the blood-brain barrier was classified using the central penetration effectiveness (CPE) score [31] . The score of each antiretroviral in a participant's regimen was summed to calculate the total CPE value for a regimen.
Neuropsychological evaluation A standard neuropsychological battery [including Trail-Making Tests A & B, the Hopkins Verbal Learning Test, and the Digit-Symbol Modalities Test (WAIS-III R)
] was administered to each participant. These tests examined memory, psychomotor speed, and executive function, and have previously been used to briefly assess HIVassociated neurocognitive disorder [32] [33] [34] . Raw scores from each test were standardized using demographic (age, sex, race, education) adjusted normative means [35, 36] . A standardized z-score was calculated by subtracting the appropriate normative mean from the raw score and then dividing by the normative standard deviation (SD). A composite neuropsychological summary Z-score (NPZ-4) was calculated by averaging z-scores from each test. For longitudinal assessments, alternate forms of the Hopkins Verbal Learning Test-Revised were administered. These different versions ensured that participants were minimally influenced by previous exposure.
Diffusion tensor imaging acquisition and analysis
All scans were performed using a 3T Siemens Tim TRIO whole-body magnetic resonance scanner (Siemens AG, Erlangen, Germany) with a product transmit/receive head coil. A T1-weighted three-dimensional magnetization-prepared rapid acquisition gradient echo (MPRAGE) sequence (time of repetition/inversion time/echo time ¼ 2400/1000/3.16 ms, flip angle ¼ 88, and voxel size ¼ 1 Â 1 Â 1 mm 3 ) was obtained. A T2weighted fast spin echo (T2W FSE) scan (time of repetition ¼ 4380 ms, echo time ¼ 94 ms, 1 Â 1 Â 3 mm) was also acquired. Images were visually inspected at the time of scanning and an additional scan was performed if significant motion artifacts were observed. Two acquisitions of diffusion-weighted images were collected for the assessment of white matter microstructural integrity (2 Â 2 Â 2 mm voxels, time of repetition ¼ 9900 ms, echo time ¼ 102 ms, flip angle ¼ 90 o , 23 directions with bvalues between 0 and 1400 s/mm 2 ).
Diffusion tensor imaging registration
A detailed review of the registration methods has been previously presented [37] . In brief, affine transforms computed by image registration were used to define the spatial relationships between all images. Multimodal image registration between the anatomical images (T2W FSE and T1W MPRAGE) was accomplished using vector gradient measure (VGM) maximization [38] . The first DTI volume (I 0 , with b ¼ 0) was registered to the T2W FSE image, which was then registered to the T1W MPRAGE image, which in turn was subsequently registered to an atlas representative target that conformed to the Tailairach system [39, 40] .
Diffusion tensor imaging motion correction
The DTI dataset was motion corrected by first aligning each DTI volume to the geometric mean volume of each group of images that shared similar degrees of diffusion sensitization. The geometric mean volume was then recomputed before aligning to the first acquired I 0 image. Next, transforms between the different images were algebraically composed. Repeating these steps three times yielded realignments with errors that had an estimated internal consistency less than 0.1 mm. All transforms were nine parameter affine (rigid body þ scanner axis stretch) computed by VGM maximization [38] . Conventional intensity correlation maximization was used to align the I 0 volumes of each DTI dataset. The final, motioncorrected results were obtained by algebraically composing all transforms and averaging datasets after application of the composed transforms using cubic spline interpolation.
Diffusion tensor imaging computations
Diffusion tensor imaging postprocessing was performed using previously described methods [41] . Briefly, the diffusion tensor and its three eigenvalues were calculated using log-linear regression in each voxel [42] . Using standard methods, the three eigenvalues were used to calculate radial diffusivity, axial diffusivity, and mean diffusivity. Anisotropy was expressed as fractional anisotropy, which is normalized to assume a range from 0 to 1. Diffusion parameters were measured and sampled for each individual by averaging particular regions of interest within the corpus callosum and CSO.
Region-of-interest analysis
Diffusion tensor imaging parameters were obtained for the genu, body, and splenium of the corpus callosum and the CSO using manually drawn regions of interest (ROIs) created in Analyze (Mayo Clinic, Rochester, Minnesota, USA; Fig. 1 ). ROIs for the corpus callosum were manually delineated by estimating anatomical boundaries agreed upon by two trained raters (P.W. and J.H.). The genu, body, and splenium of the corpus callosum were drawn on the mid-sagittal slice of each participant's fractional anisotropy map. Each region was sampled across five slices that were centered upon this slice. Each DTI parameter reflects the average of these five slices. ROIs for the bilateral CSO were also manually drawn in atlas space and were sampled from three axial slices superior to the lateral ventricles. These two regions are representative brain white matter tracts. The corpus callosum is representative of commissural white matter and is involved in inter-hemispheric communication, whereas the CSO represents projection white matter which provides communication between the cortex and the cerebrum.
Statistical analysis
Demographic variables (including sex and neuropsychological performance) were compared across groups using an analysis of variance (ANOVA). In addition, Student's ttests were performed comparing clinical variables (CD4 cell count, nadir CD4 cell count, and log 10 plasma HIV viral load) between HIVþ/cARTÀ and HIVþ/cARTþ patients. DTI parameters were log-transformed to improve normality with the transformed values. These log-transformed values were subsequently used in all analyses. Pearson's correlation coefficients were computed to assess the relationship between DTI parameters in each of the ROIs and NPZ-4 scores. For each of the corpus callosum regions and the CSO, a one-way ANOVA was used to compare DTI parameters across groups for the cross-sectional analysis. Significance was set at an uncorrected value of P less than 0.05. Paired Student's t-tests were employed to compare the subset of 10 HIV-infected individuals who had DTI and neuropsychological performance testing performed prior to and approximately 6 months after receiving stable cART.
Results
Participant demographics
Cross-sectional demographic variables for the three groups (HIV-uninfected controls, HIVþ/cARTÀ, HIVþ/cARTþ) are shown in Table 1 . There were no significant differences among the groups in regard to age, sex, or education. Neuropsychological performance (NPZ-4 score) did not significantly differ for the three groups. The HIVþ/cARTþ group had significantly (P < 0.01) lower log 10 plasma HIV viral load and nadir CD4 cell counts than the HIVþ/cARTÀ group. In general, HIVþ/cARTþ patients had been infected longer than HIVþ/cARTÀ individuals. The median CPE score for the HIVþ/cARTþ group was 7. No significant differences in current CD4 cell count were seen between the two HIVþ groups.
HIVR/cARTS group had significant decreases in diffusion tensor imaging parameters compared to HIV-uninfected controls and HIVR/cARTR group As seen in Table 2 , decreases in mean diffusivity, axial diffusivity, and radial diffusivity (P < 0.01) were observed for each of the corpus callosum regions as well as the CSO for the HIVþ/cARTÀ group compared to either HIVþ/cARTþ or HIV-uninfected control groups. No significant differences were seen between HIVþ/ cARTþ and HIV-uninfected control patients. Moreover, fractional anisotropy values were similar among the three groups. For the two HIV-infected groups, DTI parameters did not correlate with either NPZ-4 measures or laboratory values (data not shown).
Initiation of combination antiretroviral therapy in HIV-infected individuals led to improvements in diffusion tensor imaging parameters
For the 10 HIV-infected participants that were followed longitudinally, increases in mean diffusivity, axial diffusivity, and radial diffusivity (P < 0.01) were observed after starting medications. For some patients who had recently received cART, mean diffusivity, axial diffusivity, and radial diffusivity values were comparable to those seen in HIV-infected participants who had chronically received cART. Of note, significant changes were seen primarily within 4 of the 10 participants (Fig. 2) . No changes in fractional anisotropy were seen in the HIV-infected 1504 AIDS 2012, Vol 26 No 12 participants after starting medications. In general, whereas mean diffusivity, axial diffusivity, and radial diffusivity were inversely correlated with decreases in log 10 plasma viral load, none of these comparisons were significant. In addition, neuropsychological performance did not improve significantly, after starting medications (P ¼ 0.43).
Discussion
The study suggests that DTI parameters within the corpus callosum and CSO are reduced in HIV-infected patients that are naïve to cART. Mean diffusivity, axial diffusivity, and radial diffusivity may normalize in some HIVinfected patients after initiating stable cART. In particular, DTI parameters in some HIV-infected individuals who recently received stable cART were comparable to those seen in HIV-infected patients on stable long-term therapy. Observed changes in DTI values did not correlate with typical laboratory or neuropsychological performance measures.
A loss of white matter integrity has been previously described due to HIV infection [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . The most common pattern observed in HIV-infected patients is an increase in mean diffusivity and a decrease in fractional anisotropy [13, 19, 27, 29, 43] . Similar changes in DTI metrics have been seen in other neurodegenerative disorders including Alzheimer's disease and multiple sclerosis [11, 44, 45] . In contrast, we observed a decrease in axial diffusivity, mean diffusivity, and radial diffusivity and no changes in fractional anisotropy in HIV-infected patients naive to cART. The observed decreases in diffusivity measures (mean diffusivity, axial diffusivity, and radial diffusivity) that are presented within this study are similar to previous investigations of cellular tumors, brain abscesses, and metabolic disorders such as phenylketonuria (PKU) [46] [47] [48] . Our understanding of the microscopic correlates of these DTI changes remains incomplete but may vary for these disorders. In particular, observed decreases in diffusivity seen for tumors, such as lymphoma or small round blue cell tumors, may be related to their high cellularity [46] . In the case of bacterial abscesses, observed decreases in diffusivity are likely related to an increase in proteinaceous content from suppurative exudate [47] . Decreases in mean diffusivity in PKU may reflect myelin damage from status spongiosis or the accumulation of intracellular debris produced as a byproduct of inadequate phenylalanine metabolism [49, 50] . For some of the above diseases, changes in diffusivity can occur symmetrically in both axial diffusivity and radial diffusivity such that no observable changes are seen in fractional anisotropy. In regards to HIV, observed decreases in axial diffusivity, radial diffusivity, and mean diffusivity seen in HIVþ/cARTÀ individuals may reflect macrophage and microglia infiltration due to active viral replication within the CNS or edema. It is believed that HIV enters the brain through infected macrophages via a Trojan horse mechanism [51] . Once inside the brain macrophages and microglia can release viral proteins, chemokines, and cytokines that in turn activate uninfected macrophages and microglia. This can propagate neuroinflammation and edema within the brain. The increased presence of these inflammatory cells, as well as surrounding debris, could decrease the free path of water diffusion [52] .
Normalization of DTI diffusivity parameters was seen in HIV-infected patients receiving long-term cART as well as some HIV-infected participants who had more recently initiated cART. Initiation of cART could lead to a reduction in viral replication and a corresponding decrease in inflammatory cells and edema within the CNS. Observed changes in DTI parameters may be more sensitive to inflammatory changes compared to neuropsychological testing as similar cognitive performance values were observed before and after starting cART. Additional studies are required correlating DTI parameters with cerebral spinal fluid measurements of HIV viral load and inflammation.
The current study has several limitations. First, our study focused on a limited number of regions. The corpus callosum and CSO were chosen as these white matter regions can be easily delineated and have been previously investigated in DTI studies [13, 19, 21, 24, 27, 29, 43] . Future studies that include additional white matter regions would allow us to determine if observed changes are particular to certain white matter regions or if these changes occur throughout the brain. Second, we did not obtain cerebrospinal fluid measurements of HIV viral load. Third, we were unable to differentiate the efficacy of cART in the CNS based on CPE scores as most participants received only a limited number of regimens due to both patient and provider preferences. The relative degree of improvements in DTI parameters could be influenced by cART penetration into the CNS. Further studies investigating the effects of CPE on DTI measures are therefore needed. Additionally, we were unable to measure medication compliance as pill counting was not performed. In general, most of the HIVþ/cARTþ patients (>70%) were virologically suppressed, providing at least some support that these individuals were taking their prescribed medicines. Finally, this study was unable to determine the optimal time for initiating therapy as only chronically HIV-infected patients were studied. Additional studies of HIV-infected patients with primary HIV infection (either acute and/or early HIV infection) are needed.
In summary, the data presented here suggest a possible role for DTI for understanding the pathophysiological effects of HIV on white matter structural integrity. Our results support the use of cART for treating HIV-infected individuals, as some HIV-infected individuals initiating therapy have improvements in DTI parameters that are comparable to those seen in HIV-uninfected individuals.
